Afford Health is a technology company.
Afford Health has raised $170K across 1 funding round.
Afford Health has raised $170K in total across 1 funding round.
Afford Health has raised $170K in total across 1 funding round.
Afford Health's investors include Cultivation Capital, MATH Venture Partners.
Afford Medical Technologies Pvt. Ltd. (often referred to as Affordmed) is a Hyderabad-based technology company specializing in affordable medical device support and solutions for hospitals, labs, and medical institutions across India and beyond.[1] Founded from a 1998 partnership, it provides turnkey products, services, and long-term support in specialties like critical care, cardiovascular surgery, orthopedics, and diagnostics, emphasizing affordability, technology, and innovation to democratize access in budget-constrained settings.[1] The company bundles customized offerings with buy-back options and sustained partnerships, serving a pan-India base while expanding to markets like Nigeria, Fiji, and Myanmar.[1]
No single "Afford Health" entity matches the query precisely, but Affordmed aligns closest as a tech-enabled medtech firm solving equipment affordability and support gaps; alternatives like Gurugram's Affordplan (a 2016 fintech for healthcare financing, serving 500,000+ users via hospital partnerships) or U.S.-focused TailorMed (2017 patient financial navigation tech) operate in adjacent affordability spaces but differ in focus.[2][3]
Afford Medical Technologies traces its roots to Technomed, a partnership formed in 1998 by dedicated biomedical engineers in Hyderabad, India, evolving into the private limited company (CIN: U72200TG2007PTC056067) around 2007.[1] A key figure is its entrepreneurial leader, who began in 1998 democratizing medical devices for Indian hospitals, later pioneering indigenous diagnostics manufacturing via Dalko Diagnostics Private Limited since 2010, and extending reach to developing economies.[1] Early traction came from addressing critical procedure needs with timely pan-India support, building on decades of biomedical expertise to prioritize affordability amid budget constraints.[1]
Affordmed rides the global medtech affordability wave in emerging markets, where rising healthcare demands clash with budget limits, amplified by post-pandemic supply chain shifts favoring localized manufacturing.[1] Timing aligns with India's "Make in India" push and diagnostics self-reliance since 2010, positioning it against imports amid 10-15% annual medtech growth in developing economies.[1] Market forces like hospital expansion in tier-2/3 cities and international aid for underserved regions (e.g., Fiji, Myanmar) favor its model, influencing the ecosystem by enabling smaller institutions to adopt advanced tech without premium costs.[1]
Affordmed is poised for expansion through deeper emerging-market penetration and potential scaling of indigenous innovations like diagnostics, leveraging its affordability edge amid rising global healthcare inequities.[1] Trends like AI-driven device maintenance and telemedicine integration could amplify its support services, while regulatory tailwinds in India bolster manufacturing. Its influence may evolve from regional enabler to key player in sustainable medtech for the Global South, sustaining the mission of tech-driven access that began in 1998.[1]
Afford Health has raised $170K across 1 funding round. Most recently, it raised $170K Seed in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2024 | $170K Seed | Cultivation Capital, MATH Venture Partners |